A mission-driven, commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide. Our solutions apply the power of functional genomic profiling to help physicians guide the care of women throughout their patient journey, from initial diagnosis to remission and cure, or recurrence and metastatic disease.
Lead Underwriter
Citigroup Global Markets Inc, Cowen and Company, LLC, Goldman Sachs & Co. LLC, Stifel Nicolaus & Company, Incorporated
